"One key issue that has arisen in funded patent litigation is transparency—in other words, to what extent must funder ...

Patent litigation takes place in the federal courts and is particularly common in industries such as pharmaceuticals, biotechnology, medical devices, mechanical devices, software, and electronics.

In this case, discretionary denial was favored because the challenged patent was dismissed with prejudice from the litigation on March 2, 2025, and because the patent “has been in force since as ...